Cortical/Subcortical Disease Burden and Cognitive Impairment in Patients with Multiple Sclerosis

References

1. ↵
   Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: frequency, patterns and prediction. Neurology 1991;41:685-691

   Abstract/FREE Full Text
2. ↵
   Comi G, Filippi M, Martinelli V, et al. Brain MR correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-227

   CrossRefPubMedWeb of Science
3. ↵
   Ormerod IEC, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579-1616

   CrossRefPubMedWeb of Science
4. ↵
   Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-166

   Abstract/FREE Full Text
5. ↵
   Swirsky-Sacchetti T, Mitchell DR, Seward J, et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992;42:1291-1295

   Abstract/FREE Full Text
6. Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994;44:420-425

   Abstract/FREE Full Text
7. ↵
   Foong J, Rozewicz L, Quaghebeur G, et al. Executive functions in multiple sclerosis: the role of frontal lobe pathology. Brain 1997;120:15-26

   CrossRefPubMedWeb of Science
8. ↵
   Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608

   Abstract/FREE Full Text
9. ↵
   Miki Y, Grossman RI, Udupa JK, et al. Isolated U-fiber involvement in MS: preliminary observations. Neurology 1998;50:1301-1306

   Abstract/FREE Full Text
10. ↵
    Moriarty DM, Blackshaw A, Talbot PR, et al. Memory dysfunction in multiple sclerosis correlates with juxtacortical lesion load demonstrated by fast FLAIR magnetic resonance imaging. In: Proceedings of Seventh Scientific Meeting of the International Society for Magnetic Resonance in Medicine. Philadelphia: 1999;940
11. ↵
    Damian MS, Schilling G, Bachmann G, Simon C, Stoppler S, Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand 1994;90:430-436

    PubMedWeb of Science
12. ↵
    Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-320

    FREE Full Text
13. Lumdsen CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: North-Holland; 1970;9:217-309
14. ↵
    Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26

    CrossRefPubMedWeb of Science
15. ↵
    Filippi M, Yousry TA, Baratti C, et al. Quantitative assessment of MR lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119:1349-1355

    CrossRefPubMed
16. Gawne-Cain ML, O'Riordan JI, Thompson AJ, Moseley IF, Miller DH. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin-echo. Neurology 1997;49:364-370

    Abstract/FREE Full Text
17. ↵
    Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515

    CrossRefPubMedWeb of Science
18. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91

    CrossRefPubMedWeb of Science
19. ↵
    Adams CMW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15-20

    PubMedWeb of Science
20. ↵
    Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

    CrossRefPubMedWeb of Science
21. ↵
    van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636

    PubMedWeb of Science
22. ↵
    Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MR. Neurology 1999;52:588-594

    Abstract/FREE Full Text
23. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617

    Abstract/FREE Full Text
24. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
25. ↵
    Peyser JM, Edwards KR, Poser CM, Filskov SB. Cognitive function in patients with multiple sclerosis. Arch Neurol 1980;37:577-579

    CrossRefPubMedWeb of Science
26. Badeley A, Della Sala S, Papagno C, Spinnler H. Dual task performance in dysexecutive and non dysexecutive patients with a frontal lesion. Neuropsychology 1997;11:187-194

    CrossRefPubMedWeb of Science
27. Weigl E. On the psychology of the so called processes of abstraction. J Abnorm Soc Psychol 1927;36:3-33
28. Heaton RH. Wisconsin Card Sorting Test (Manual).. Odessa, FL: Psychological Assessment Resources; 1981
29. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662

    CrossRefWeb of Science
30. Pozzilli C, Bastianello S, Padovani A, et al. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex 1991;27:441-445

    CrossRefPubMedWeb of Science
31. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982;298:199-209

    CrossRefPubMedWeb of Science
32. Pagano G, Valla RG. Verbal and special immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987;8:539-548

    CrossRefPubMedWeb of Science
33. ↵
    Spinnler H, Tognoni G. Standardizzazione e Taratura Italiana di Test Neuropsicologici.. Milan, Masson; 1987
34. ↵
    Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688

    Abstract/FREE Full Text
35. ↵
    Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new MR putative markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266-270

    CrossRefPubMedWeb of Science
36. ↵
    Gonzales RC, Woods RE. Digital Image Processing.. Reading, MA: Addison-Wesley; 1992;518-559
37. ↵
    Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452

    Abstract/FREE Full Text
38. ↵
    Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911

    Abstract/FREE Full Text
39. ↵
    Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482

    Abstract/FREE Full Text
40. ↵
    De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997;49:1138-1141

    Abstract/FREE Full Text
41. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MR correlates with disease progression in multiple sclerosis. Neurology 1997;47:1469-1476

    Abstract/FREE Full Text
42. ↵
    Gasperini C, Paolillo A, Giugni E, et al. Effect of interferon beta 1a on MR brain volume in relapsing remitting multiple sclerosis. Neurology 1999;52: (Suppl 2):A 379
43. Simon JH, Miller DE, Lull J, Sheeder J, Simonian N, Jacobs L. Natural history and effect of IFN β-1a (Avonex) on T1-hypointense lesions (T1 “black holes”). Neurology 1999;52(Suppl 2):378
44. ↵
    van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MR in multiple sclerosis. Neurology 1998;50:1282-1288

    Abstract/FREE Full Text